Carregant...
Interpreting Effect Sizes and Clinical Relevance of Pharmacological Interventions for Fibromyalgia
Duloxetine, milnacipran, and pregabalin are approved by the United States Food and Drug Administration for the management of fibromyalgia. A number of meta-analyses, pooled analyses, and systematic reviews have been published in recent years involving the efficacy of these three medications for pain...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Healthcare
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4107878/ https://ncbi.nlm.nih.gov/pubmed/25135038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40122-013-0011-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|